Significance of urinary albumin excretion in patients with cast nephropathy


Clinical Nephrology
|June 25, 2019
PubMed
Abstract

Insights

Urinary albumin excretion rate (%UAE) can help differentiate myeloma cast nephropathy (MCN) with or without glomerular amyloidosis. Lower %UAE suggests MCN without amyloid, potentially indicating a better prognosis.

Area of Science:

  • Nephrology
  • Oncology
  • Pathology

Background:

  • Myeloma cast nephropathy (MCN) is a kidney disease associated with multiple myeloma.
  • Distinguishing MCN with glomerular amyloid deposition from MCN without it is clinically important.
  • The role of urinary albumin excretion rate (%UAE) in this differentiation is unclear.

Purpose of the Study:

  • To investigate if %UAE can differentiate MCN with glomerular amyloid deposition from MCN without it.
  • To assess the clinical utility of %UAE in identifying coexisting glomerular lesions in MCN.

Main Methods:

  • Retrospective review of clinicopathological data from 16 MCN patients diagnosed via renal biopsy.
  • Patients were categorized into two groups: pure MCN (group 1) and MCN with glomerular amyloid deposition (group 2).
  • Comparison of laboratory parameters, including %UAE, serum albumin, and creatinine, between the two groups.

Main Results:

  • Group 1 (pure MCN) had significantly higher serum albumin and lower %UAE compared to Group 2 (MCN with amyloidosis).
  • Serum creatinine was significantly higher in Group 1, while total protein and serum-adjusted calcium showed no significant differences.
  • Patients in Group 2 with multiple myeloma had a poorer survival outcome compared to those with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.

Conclusions:

  • Lower %UAE may indicate MCN without glomerular amyloid deposition.
  • %UAE could serve as a valuable biomarker for detecting coexisting glomerular lesions like amyloidosis in MCN patients.
  • The presence of glomerular lesions, indicated by higher %UAE, is associated with a poorer prognosis in MCN.

Related Concept Videos

One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
615
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
243
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
Statistical Significance01:50

Statistical Significance

Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
21.2K
What Are Osmoregulation and Excretion?02:12

What Are Osmoregulation and Excretion?

Organisms must keep bodily fluids at a constant temperature and pH while maintaining specific solute concentrations in order to support life functions. Osmoregulation is the process that balances solute and water levels.
38.0K